Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration : Pralsetinib-induced acute confusional state
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Acta oncologica (Stockholm, Sweden) - 61(2022), 7 vom: 07. Juli, Seite 819-823 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shachar, Eliya [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EC 2.7.10.1 |
|---|
| Anmerkungen: |
Date Completed 24.06.2022 Date Revised 29.06.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/0284186X.2022.2071111 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34056170X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34056170X | ||
| 003 | DE-627 | ||
| 005 | 20231226005618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/0284186X.2022.2071111 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1135.xml |
| 035 | |a (DE-627)NLM34056170X | ||
| 035 | |a (NLM)35527711 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shachar, Eliya |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration |b Pralsetinib-induced acute confusional state |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.06.2022 | ||
| 500 | |a Date Revised 29.06.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Pyrazoles |2 NLM | |
| 650 | 7 | |a Pyridines |2 NLM | |
| 650 | 7 | |a Pyrimidines |2 NLM | |
| 650 | 7 | |a pralsetinib |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Proteins c-ret |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 650 | 7 | |a RET protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Peleg Hasson, Shira |e verfasserin |4 aut | |
| 700 | 1 | |a Blumenthal, Deborah T |e verfasserin |4 aut | |
| 700 | 1 | |a Fraenkel, Meerav |e verfasserin |4 aut | |
| 700 | 1 | |a Uri, Yoel |e verfasserin |4 aut | |
| 700 | 1 | |a Wolf, Ido |e verfasserin |4 aut | |
| 700 | 1 | |a Grozinsky-Glasberg, Simona |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta oncologica (Stockholm, Sweden) |d 1993 |g 61(2022), 7 vom: 07. Juli, Seite 819-823 |w (DE-627)NLM012619353 |x 1651-226X |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2022 |g number:7 |g day:07 |g month:07 |g pages:819-823 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/0284186X.2022.2071111 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2022 |e 7 |b 07 |c 07 |h 819-823 | ||